| Literature DB >> 35211812 |
Jared M Campbell1, Saabah B Mahbub2, Michael J Bertoldo3,4, Abbas Habibalahi2, Dale M Goss4, William L Ledger3, Robert B Gilchrist3, Lindsay E Wu4, Ewa M Goldys2.
Abstract
Increasing age has a major detrimental impact on female fertility, which, with an ageing population, has major sociological implications. This impact is primarily mediated through deteriorating quality of the oocyte. Deteriorating oocyte quality with biological age is the greatest rate-limiting factor to female fertility. Here we have used label-free, non-invasive multi-spectral imaging to identify unique autofluorescence profiles of oocytes from young and aged animals. Discriminant analysis demonstrated that young oocytes have a distinct autofluorescent profile which accurately distinguishes them from aged oocytes. We recently showed that treatment with the nicotinamide adenine dinucleotide (NAD+) precursor nicotinamide mononucleotide (NMN) restored oocyte quality and fertility in aged animals, and when our analysis was applied to oocytes from aged animals treated with NMN, 85% of these oocytes were classified as having the autofluorescent signature of young animals. Spectral unmixing using the Robust Dependent Component Analysis (RoDECA) algorithm demonstrated that NMN treatment altered the metabolic profile of oocytes, increasing free NAD(P)H, protein bound NAD(P)H, redox ratio and the ratio of bound to free NAD(P)H. The frequency of oocytes with simultaneously high NAD(P)H and flavin content was also significantly increased in mice treated with NMN. Young and Aged + NMN oocytes had a smoother spectral distribution, with the distribution of NAD(P)H in young oocytes specifically differing from that of aged oocytes. Identifying the multispectral profile of oocyte autofluorescence during aging could have utility as a non-invasive and sensitive measure of oocyte quality.Entities:
Keywords: Ageing; Autofluorescence; Hyperspectral; Multispectral; Oocyte; Reproductive healthcare
Mesh:
Substances:
Year: 2022 PMID: 35211812 PMCID: PMC9023381 DOI: 10.1007/s10522-022-09957-y
Source DB: PubMed Journal: Biogerontology ISSN: 1389-5729 Impact factor: 4.284
Fig. 1Spectral (channel 2) and brightfield representative images of oocytes from a young, b aged and c Aged mice treated with NMN
Fig. 2Modelling of multispectral feature data categorising oocytes into Young (blue), Aged (red) and Aged treated with NMN (green)
Fig. 3Relative abundance of A NAD(P)H, B Flavins, C protein bound NAD(P)H (b-NAD(P)H), D Collagen, E Redox ratio (NAD(P)H vs.Flavins) and F protein bound vs. free NAD(P)H. * indicates p < 0.05, *** indicates p < 0.0001
Fig. 4Heatmap for NAD(P)H, flavins, and Redox ratio for Young, Aged control, and Aged + NMN treatments
Fig. 5Spatial distribution of flavins and NAD(P)H assessed by concentration gradient of flavins (a) and NAD(P)H (b) within Young, Aged and Aged + NMN oocytes. ** indicates p < 0.005
High and low NAD(P)H and flavins in individual oocytes
| Young | Aged | NMN | |
|---|---|---|---|
| High NAD(P)H | 14 (52%) | 6 (29%) | 20 (77%) |
| High Flavins | 13 (48%) | 11 (52%) | 14 (54%) |
| High NAD(P)H + Flavins | 5 (19%) | 1 (5%) | 11 (42%) |
| Sample (N) | 27 | 21 | 26 |
Fig. 6Free NAD(P)H plotted against flavin concentration for young, aged and aged treated with NMN oocytes